scPharmaceuticals Inc. Annual stock financials by MarketWatch. View the latest SCPH financial statements, income statements and financial ratios.

scPharmaceuticals, Inc. (SCPH) shares soared 8.8% in the last trading session to close at $5.84. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

scPharmaceuticals, Inc. (SCPH) has been on a downward spiral lately with significant selling pressure. After declining 21.8% over the past four weeks, the stock looks well positioned for a trend ...

SCPH's Furoscix, despite just launching, defied street consensus with an impressive $2.1M revenue in 1Q23, indicating a promising ramp trajectory. Witnessing a substantial increase in Furoscix's ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

scPharmaceuticals, Inc. (SCPH) closed the last trading session at $5.06, gaining 12.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of scPharmaceuticals Inc. (NASDAQ: SCPH) to MannKind Corporation is fair to scPharmaceuticals shareholders. Under the ...

scPharmaceuticals, Inc. (SCPH) shares soared 8.8% in the last trading session to close at $5.84. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...